Abvc Biopharma, Inc.
ABVC Nasdaq
SEC CIK 1173313
Follow Abvc Biopharma
Weekly email: filings, results
Net income
$1.1M
+156.3% vs same quarter last year
EPS, diluted
$0.04
+144.4% vs same quarter last year
Operating cash flow
−$438.9K
+54.5% vs same quarter last year
Operating income
−$1.2M
+36.8% vs same quarter last year
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $296K | −$7.9M |
| FY24 | $509.6K | −$4.9M |
| FY23 | $152.4K | −$7.8M |
| FY22 | $969.8K | −$16.4M |
| FY21 | $355.8K | −$12.8M |
| FY20 | $483K | −$10.6M |
| FY19 | $701.7K | −$3.9M |
| FY18 | $7K | −$6.1M |
| FY17 | - | −$4.2M |
| FY16 | - | −$11M |
| FY15 | $3.4K | −$32.3K |
| FY14 | $0 | −$70 |
| FY13 | $7.8K | −$226.4K |
| FY12 | $5.7K | −$1.1M |
| FY11 | $3.2K | −$1.2M |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | - | −2416% | −2671.8% |
| FY24 | 99.9% | −923.3% | −962.1% |
| FY23 | −98.1% | −4439.2% | −5109.3% |
| FY22 | 70.5% | −1558.5% | −1693.5% |
| FY21 | 98.6% | −3290.1% | −3608.5% |
| FY20 | 96.1% | −1760.9% | −2193.1% |
| FY19 | 97.1% | −492.9% | −560.5% |
| FY18 | −2563.6% | −40031.1% | −87184.2% |
| FY17 | - | - | - |
| FY16 | - | - | - |
| FY15 | 84.5% | - | −960.7% |
| FY14 | - | - | - |
| FY13 | - | −2276.3% | −2906.8% |
| FY12 | - | −20004.3% | −18718.6% |
| FY11 | - | −59180.7% | −38202.2% |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | - |
| FY24 | - |
| FY23 | −$4.2M |
| FY22 | −$7.5M |
| FY21 | −$7.6M |
| FY20 | - |
| FY19 | - |
| FY18 | - |
| FY17 | - |
| FY16 | - |
| FY15 | - |
| FY14 | - |
| FY13 | −$37.8K |
| FY12 | −$915.5K |
| FY11 | −$1.6M |
- Abvc Biopharma
- Healthcare median
Show the numbers
| Year | Abvc Biopharma | Healthcare median |
|---|---|---|
| FY25 | −2671.8% | −30.6% |
| FY24 | −962.1% | −47% |
| FY23 | −5109.3% | −58% |
| FY22 | −1693.5% | −80.4% |
| FY21 | −3608.5% | −71.8% |
| FY20 | −2193.1% | −62.2% |
| FY19 | −560.5% | −46.2% |
| FY18 | −87184.2% | −49.6% |
| FY17 | - | −45.9% |
| FY16 | - | −36% |
| FY15 | −960.7% | −37.8% |
| FY14 | - | −35.5% |
| FY13 | −2906.8% | −37.1% |
| FY12 | −18718.6% | −29.1% |
| FY11 | −38202.2% | −27.9% |